Takeda Pharmaceutical
TAK
#489
Rank
โ‚ฌ40.63 B
Marketcap
12,21ย โ‚ฌ
Share price
0.28%
Change (1 day)
-3.93%
Change (1 year)

Takeda Pharmaceutical (TAK) - Cash on Hand

Cash on Hand as of September 2025 : โ‚ฌ4.29 Billion

According to Takeda Pharmaceutical's latest financial reports the company has โ‚ฌ4.29 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Takeda Pharmaceutical - Cash on Hand chart (from 2008 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2025-03-31โ‚ฌ2.50 B-13.59%
2024-03-31โ‚ฌ2.89 B-24.29%
2023-03-31โ‚ฌ3.82 B-41.11%
2022-03-31โ‚ฌ6.49 B-15.93%
2021-03-31โ‚ฌ7.72 B40.06%
2020-03-31โ‚ฌ5.51 B-5.33%
2019-03-31โ‚ฌ5.82 B103.18%
2018-03-31โ‚ฌ2.86 B-9.33%
2017-03-31โ‚ฌ3.16 B-27.76%
2016-03-31โ‚ฌ4.37 B-20.96%
2015-03-31โ‚ฌ5.53 B-7.52%
2014-03-31โ‚ฌ5.98 B28.63%
2013-03-31โ‚ฌ4.65 B11.7%
2012-03-31โ‚ฌ4.16 B-43.76%
2011-03-31โ‚ฌ7.40 B6.91%
2010-03-31โ‚ฌ6.92 B19.28%
2009-03-31โ‚ฌ5.80 B-44.3%
2008-03-31โ‚ฌ10.42 B-9%
2007-03-31โ‚ฌ11.45 B-13.49%
2006-03-31โ‚ฌ13.24 B20.94%
2005-03-31โ‚ฌ10.95 B6.61%
2004-03-31โ‚ฌ10.27 B14.78%
2003-03-31โ‚ฌ8.95 B17.5%
2002-03-31โ‚ฌ7.61 B16.8%
2001-03-31โ‚ฌ6.52 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ15.94 B 271.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚ฌ8.97 B 109.12%๐Ÿ‡ซ๐Ÿ‡ท France
Pfizer
PFE
โ‚ฌ12.86 B 199.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚ฌ8.37 B 95.14%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Seagen
SGEN
โ‚ฌ1.06 B-75.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Dr. Reddy's Laboratories
RDY
โ‚ฌ0.67 B-84.28%๐Ÿ‡ฎ๐Ÿ‡ณ India
Amgen
AMGN
โ‚ฌ8.11 B 88.98%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
โ‚ฌ3.81 B-11.08%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
โ‚ฌ15.64 B 264.43%๐Ÿ‡บ๐Ÿ‡ธ USA